MC38-hHER3
Strain Information
검증 데이터
Fig1. hHER3 expression on in vitro cultured cells of MC38-hHER3.
Fig2. In vivo validation of MC38-hHER3 in C57BL/6 mice.
C57BL/6 mice were inoculated with MC38-hHER3 subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig3. hHER3 expression in tumors after in vivo growth of MC38-hHER3 in wild type C57BL/6 mice.
The tumors were collected at day 33 post tumor cell inoculation.
Related Strain(s)
당신은 또한 좋아할 수 있습니다
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
조회At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
조회